Bioprocessing Application Notes & Case Studies

  1. Automated Enrichment Of Human CD34+ Cells 7/28/2026

    Discover an automated strategy for enriching CD34+ cells, combining streamlined processing, strong purity and viability metrics, and reduced hands-on effort to support stem cell engineering.

  2. Automated Enrichment Of Human CD34+ Cells 7/28/2026

    Explore an automated approach to CD34+ cell enrichment that combines scalable processing and high-purity cell recovery, offering insight into performance metrics and practical considerations.

  3. Memory T Cells – Depletion Of CD45RA+ Cells 7/28/2026

    Learn how selective depletion of CD45RA-positive cells helps preserve pathogen-specific memory T cells, reduce potentially alloreactive populations, and support immune reconstitution strategies.

  4. Single-Use Virus Filtration: Controllers And Systems For Modern Bioprocessing 7/24/2026

    Modern single-use virus filtration automates critical processing steps, slashes turnaround times, and optimizes scalability across bioprocessing workflows.

  5. Perfusion Cultivations With ExpiCHO-S Cells Using The Minifors 2 Bioreactor 7/21/2026

    High-density perfusion cultivation can support stronger productivity in a smaller footprint. See how integrated cell retention and process control enabled rapid growth, high viable cell densities, and strong IgG titres in eight days.

  6. Automated Fill And Finish For Cell Therapy 7/20/2026

    Automated fill-finish systems protect sensitive cell therapies using low-shear handling to maintain dose uniformity, cell viability, and process consistency across every batch.

  7. Aligning Scientific Expertise To Accelerate Complex Biologics Programs 7/17/2026

    Complex biologics often outgrow traditional development platforms. Learn how an integrated development strategy can accelerate timelines while reducing risk.

  8. CLD Case Study: Complex Biologics – Bispecific Fusion Nanobody 7/17/2026

    See how a bispecific fusion nanobody (BFN) achieved BsAb titers above 7 g/L with 5 of 6 clones stable beyond 60 generations — from CLD through cGMP manufacturing.

  9. Unlocking Robust Separations For Modern Peptide Therapeutics 7/14/2026

    As peptide therapeutics grow more complex, impurity profiling demands greater chromatographic confidence. See how robust reproducibility can support reliable GLP-1 receptor agonist analysis.

  10. Using dSEC-7 Column For Separation And Length Determination Of mRNA 7/13/2026

    mRNA analysis depends on methods that can separate broad size ranges. Learn how retention time can help estimate transcript length and complement capillary electrophoresis workflows.